The Attomarker panel for fertility will allow clinics and physicians to assess some of the key hormones in the reproductive process in just 7 minutes within a single consultation, allowing conception to be optimised and then hCG monitored to follow the growth of the baby in the first trimester.
Additionally, the test will also help clinics, physicians and patients manage hormone replacement therapy through the menopause in a much more precise and targeted manner.
